• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Cancer research: Are the drugs we count on based on bad science? 27 October 2013
How effective is chemo therapy? 07 October 2013
Long-term side-effects. Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost? 19 July 2013
Are we treating cancer, but killing the patient? 06 April 2013
Radiation generates cancer stem cells from less aggressive breast cancer cells! 22 February 2013
Melatonin's role in cancer 17 January 2013
Chemo can backfire, make cancer worse! 12 December 2012
Display # 

Search

Follow us...

Latest

  • Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress
  • Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
  • Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1
  • Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
  • From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer
  • Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect
  • Protective effects of exogenous melatonin therapy against oxidative stress to male reproductive tissue caused by anti-cancer chemical and radiation therapy: a systematic review and meta-analysis of animal studies
  • Melatonin Prevents Depression but Not Anxiety-like Behavior Produced by the Chemotherapeutic Agent Temozolomide: Implication of Doublecortin Cells and Hilar Oligodendrocytes
  • Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience
  • Resolution of thymoma-related pure red cell aplasia after octreotide treatment
  • Of sight, and insight into melatonin’s role in breast cancer?
  • Melatonin modulates tumor metabolism and mitigates metastasis
  • Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants
  • Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
  • Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats
  • Efficacy, mechanism, and safety of melatonin-loaded on thermosensitive nanogels for rabbit VX2 tumor embolization: A novel design
  • Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia
  • Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • How effective is chemo therapy?
  • Vademecum
  • Frequently Asked Questions
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients